Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2009-2-20
pubmed:abstractText
We made a disease-specific comparison of unrelated cord blood (CB) recipients and human leukocyte antigen allele-matched unrelated bone marrow (BM) recipients among 484 patients with acute myeloid leukemia (AML; 173 CB and 311 BM) and 336 patients with acute lymphoblastic leukemia (ALL; 114 CB and 222 BM) who received myeloablative transplantations. In multivariate analyses, among AML cases, lower overall survival (hazard ratio [HR]=1.5; 95% confidence interval [CI], 1.0-2.0, P= .028) and leukemia-free survival (HR=1.5; 95% CI, 1.1-2.0, P= .012) were observed in CB recipients. The relapse rate did not differ between the 2 groups of AML (HR=1.2; 95% CI, 0.8-1.9, P= .38); however, the treatment-related mortality rate showed higher trend in CB recipients (HR=1.5; 95% CI, 1.0-2.3, P= .085). In ALL, there was no significant difference between the groups for relapse (HR=1.4, 95% CI, 0.8-2.4, P= .19) and treatment-related mortality (HR=1.0; 95% CI, 0.6-1.7, P= .98), which contributed to similar overall survival (HR=1.1; 95% CI, 0.7-1.6, P= .78) and leukemia-free survival (HR=1.2; 95% CI, 0.9-1.8, P= .28). Matched or mismatched single-unit CB is a favorable alternative stem cell source for patients without a human leukocyte antigen-matched related or unrelated donor. For patients with AML, decreasing mortality, especially in the early phase of transplantation, is required to improve the outcome for CB recipients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1528-0020
pubmed:author
pubmed:issnType
Electronic
pubmed:day
19
pubmed:volume
113
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1631-8
pubmed:meshHeading
pubmed-meshheading:19104080-Adolescent, pubmed-meshheading:19104080-Adult, pubmed-meshheading:19104080-Aged, pubmed-meshheading:19104080-Blood Platelets, pubmed-meshheading:19104080-Bone Marrow Transplantation, pubmed-meshheading:19104080-Cause of Death, pubmed-meshheading:19104080-Cord Blood Stem Cell Transplantation, pubmed-meshheading:19104080-Disease-Free Survival, pubmed-meshheading:19104080-Female, pubmed-meshheading:19104080-Follow-Up Studies, pubmed-meshheading:19104080-Graft vs Host Disease, pubmed-meshheading:19104080-Histocompatibility Testing, pubmed-meshheading:19104080-Humans, pubmed-meshheading:19104080-Incidence, pubmed-meshheading:19104080-Leukemia, Myeloid, Acute, pubmed-meshheading:19104080-Male, pubmed-meshheading:19104080-Middle Aged, pubmed-meshheading:19104080-Multivariate Analysis, pubmed-meshheading:19104080-Neutrophils, pubmed-meshheading:19104080-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:19104080-Recurrence, pubmed-meshheading:19104080-Risk Factors, pubmed-meshheading:19104080-Treatment Outcome, pubmed-meshheading:19104080-Young Adult
pubmed:year
2009
pubmed:articleTitle
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
pubmed:affiliation
Department of Hematopoietic Stem Cell Transplantation Data Management, Nagoya University School of Medicine, Higashi-ku Nagoya, Japan. y-atsuta@med.nagoya-u.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't